UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparison of the toxicity profile of PD‐1 versus PD‐L1 inhibitors in non–small cell lung cancer: A systematic analysis of the literature

Cancer, 2018-01, Vol.124 (2), p.271-277

2018

Volltextzugriff (PDF)

Personalized therapy for lung cancer: striking a moving target

JCI insight, 2018-08, Vol.3 (15)

2018

Volltextzugriff (PDF)

Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base

Clinical lung cancer, 2017-05, Vol.18 (3), p.286-292

2017

Volltextzugriff (PDF)

Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study

Journal for immunotherapy of cancer, 2020-12, Vol.8 (2), p.e001302

2020

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Mutated Advanced Non–Small Cell Lung Cancer

Hematology/oncology clinics of North America, 2017-02, Vol.31 (1), p.83-99

2017

Volltextzugriff (PDF)

Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia

Cancer, 2012-11, Vol.118 (21), p.5278-5282

2012

Volltextzugriff (PDF)

Immune checkpoint inhibitors in small cell lung cancer

Journal of thoracic disease, 2018-02, Vol.10 (Suppl 3), p.S460-S467

2018

Volltextzugriff (PDF)

Phase Ib Study of Crizotinib plus Pembrolizumab in Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer with ALK Translocation

The oncologist (Dayton, Ohio), 2020-07, Vol.25 (7), p.562-e1012

2020

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor Mutated Advanced Non-Small Cell Lung Cancer: A Changing Treatment Paradigm

Hematology/oncology clinics of North America, 2017-02, Vol.31 (1), p.83

2017

Volltextzugriff (PDF)

Adjuvant therapy for nonsmall cell lung cancer: recent advances and future perspectives

Current opinion in oncology, 2016-03, Vol.28 (2), p.150-158

2016

Volltextzugriff (PDF)

A Phase 2 Study of Docetaxel, Ramucirumab, and Pembrolizumab for Patients With Metastatic or Recurrent Non–Small-Cell Lung Cancer (NSCLC) who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade

Clinical lung cancer, 2022-11, Vol.23 (7), p.e400-e404

2022

Volltextzugriff (PDF)

Lung Cancer in HIV-Positive Patients

Journal of thoracic oncology, 2010-11, Vol.5 (11), p.1864-1871

2010

Volltextzugriff (PDF)

Temsirolimus (T) in patients (pts) with solid tumors with mTOR mutation: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3114-3114

2022

Volltextzugriff (PDF)

Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer

Journal of translational medicine, 2016-05, Vol.14 (1), p.111-111, Article 111

2016

Volltextzugriff (PDF)

Trimodality Therapy in the Treatment of Stage III N2‐Positive Non‐Small Cell Lung Cancer: A National Cancer Database Analysis

The oncologist (Dayton, Ohio), 2020-06, Vol.25 (6), p.e964-e975

2020

Volltextzugriff (PDF)

Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non–Small Cell Lung Cancer: A Phase I Study

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.1687-1695

2017

Volltextzugriff (PDF)

KRAS G12C mutation associated outcomes among patients with locally advanced non-small cell lung cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e21079-e21079

2020

Volltextzugriff (PDF)

A Safety Analysis of Programmed Death 1 Pathway Inhibitors in Patients With Solid Tumor Malignancies and Preexisting Autoimmune Disease

Journal of clinical rheumatology, 2022-10, Vol.28 (7), p.338-345

2022

Volltextzugriff (PDF)

Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis

Head & neck, 2019-05, Vol.41 (5), p.1490-1498

2019

Volltextzugriff (PDF)

A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.8515-8515

2019

Volltextzugriff (PDF)

OA03.06 Evaluation of Toxicity Profile of PD-1 versus PD-L1 Inhibitors in Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S253-S254

2017

Volltextzugriff (PDF)

Evaluation of toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9035-9035

2016

Volltextzugriff (PDF)

Role of anti-EGFR monoclonal antibody in EGFR FISH positive NSCLC patients: A meta-analysis of phase III randomized controlled trials

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e20650-e20650

2016

Volltextzugriff (PDF)

Liver metastases and sensitivity to checkpoint inhibition in patients with non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e20665-e20665

2016

Volltextzugriff (PDF)

Optimal thoracic radiation dose in limited stage small cell lung cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.8562-8562

2017

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(14)
Oncology
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Lung Cancer
(7)
Aged
(6)
Female
(6)
Lung Neoplasms - Drug Therapy
(6)
Male
(6)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(5)
Immunotherapy
(5)
Lung Neoplasms - Pathology
(5)
Middle Aged
(5)
Adult
(4)
Carcinoma, Non-Small-Cell Lung - Pathology
(4)
Lung Neoplasms - Mortality
(4)
Neoplasm Staging
(4)
Cancer
(3)
Chemotherapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(14)
Cancer
(4)
Clinical Lung Cancer
(4)
Journal Of Thoracic Oncology
(4)
Hematology/oncology Clinics Of North America
(2)
The Oncologist
(2)
The oncologist
(2)
Blood
(1)
Current Opinion In Oncology
(1)
Head & Neck
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparison of the toxicity profile of PD‐1 versus PD‐L1 inhibitors in non–small cell lung cancer: A systematic analysis of the literature

Personalized therapy for lung cancer: striking a moving target

Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base

Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study

Epidermal Growth Factor Receptor Mutated Advanced Non–Small Cell Lung Cancer

Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia

Immune checkpoint inhibitors in small cell lung cancer

Phase Ib Study of Crizotinib plus Pembrolizumab in Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer with ALK Translocation

Epidermal Growth Factor Receptor Mutated Advanced Non-Small Cell Lung Cancer: A Changing Treatment Paradigm

Adjuvant therapy for nonsmall cell lung cancer: recent advances and future perspectives

A Phase 2 Study of Docetaxel, Ramucirumab, and Pembrolizumab for Patients With Metastatic or Recurrent Non–Small-Cell Lung Cancer (NSCLC) who Progressed on Platinum-Doublet and PD-1/PD-L1 Blockade

Lung Cancer in HIV-Positive Patients

Temsirolimus (T) in patients (pts) with solid tumors with mTOR mutation: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer

Trimodality Therapy in the Treatment of Stage III N2‐Positive Non‐Small Cell Lung Cancer: A National Cancer Database Analysis

Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non–Small Cell Lung Cancer: A Phase I Study

KRAS G12C mutation associated outcomes among patients with locally advanced non-small cell lung cancer

A Safety Analysis of Programmed Death 1 Pathway Inhibitors in Patients With Solid Tumor Malignancies and Preexisting Autoimmune Disease

Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis

A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC)

OA03.06 Evaluation of Toxicity Profile of PD-1 versus PD-L1 Inhibitors in Non-Small Cell Lung Cancer (NSCLC)

Evaluation of toxicity profile of PD-1 versus PD-L1 inhibitors in non-small cell lung cancer (NSCLC)

Role of anti-EGFR monoclonal antibody in EGFR FISH positive NSCLC patients: A meta-analysis of phase III randomized controlled trials

Liver metastases and sensitivity to checkpoint inhibition in patients with non-small cell lung cancer (NSCLC)

Optimal thoracic radiation dose in limited stage small cell lung cancer

Suchergebnisse filtern